Recursion Pharmaceuticals (RXRX) Prepaid Assets (2020 - 2026)

Recursion Pharmaceuticals' Prepaid Assets history runs 7 years deep, the most recent figure standing at $24.2 million for Q1 2026.

• Quarterly Prepaid Assets rose 881.62% year-over-year to $24.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.2 million (up 881.62% YoY) and the FY2025 annual result came in at $28.6 million, down 25.04% from the prior year.
• Prepaid Assets was $24.2 million for Q1 2026 at Recursion Pharmaceuticals, down from $28.6 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $43.7 million in Q2 2024 and bottomed at $2.5 million in Q1 2025.
• A 5-year average of $25.0 million and a median of $18.8 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2025 — Prepaid Assets sank 94.05% — and 2026, when it soared 881.62%.
• Recursion Pharmaceuticals' Prepaid Assets stood at $15.9 million in 2022, then soared by 153.62% to $40.2 million in 2023, then dropped by 5.32% to $38.1 million in 2024, then declined by 25.04% to $28.6 million in 2025, then dropped by 15.12% to $24.2 million in 2026.
• Business Quant data shows RXRX's Prepaid Assets at $24.2 million in Q1 2026, $28.6 million in Q4 2025, and $2.5 million in Q1 2025.